The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...
Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...
The 204 people randomized to IV procainamide (plus electrical cardioversion if necessary, with up to three shocks) showed a 96% rate of conversion to sinus rhythm that was maintained for at least 30 ...
ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...
New research suggests that coffee may actually help prevent atrial fibrillation recurrence after treatment, contradicting ...
Heart arrhythmias are usually harmless, but some can be life threatening. Treatments help correct your heart rate to prevent serious health issues. When the electrical impulses that affect your ...
Skip the decaf. A new study shows coffee may cut AFib recurrence after cardioversion, challenging the belief that caffeine is ...
A new study suggests that drinking a cup of coffee every day may actually lower the risk of atrial fibrillation returning in ...
According to the research, drinking just one cup of caffeinated coffee a day could actually protect against atrial ...
A new study has revealed surprising benefits of drinking coffee for your cardiovascular health.Experts have discovered that drinking a cup of coffee every day could lower the risk of heart rhythm ...
People who had a daily cup of coffee had a lower risk of new episodes of atrial fibrillation compared with people who abstained from caffeine.
Your risk of getting atrial fibrillation (AFib) goes up as you age. It’s also becoming more common. The CDC predicts over 12 million Americans will have it by the year 2030. AFib treatment can be ...